The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support.
Cecilia BerardiClaudio A BravoSong LiMaziar KhorsandiJeffrey E KeenanJonathan AuldSunny RockomJennifer A BeckmanClaudius MahrPublished in: Journal of clinical medicine (2022)
The utilization of left ventricular assist devices (LVADs) in end-stage heart failure has doubled in the past ten years and is bound to continue to increase. Since the first of these devices was approved in 1994, the technology has changed tremendously, and so has the medical and surgical management of these patients. In this review, we discuss the history of LVADs, evaluating survival and complications over time. We also aim to discuss practical aspects of the medical and surgical management of LVAD patients and future directions for outcome improvement in this population.
Keyphrases
- heart failure
- left ventricular
- end stage renal disease
- ejection fraction
- chronic kidney disease
- healthcare
- newly diagnosed
- left ventricular assist device
- aortic stenosis
- peritoneal dialysis
- acute myocardial infarction
- type diabetes
- adipose tissue
- metabolic syndrome
- skeletal muscle
- extracorporeal membrane oxygenation
- weight loss
- insulin resistance
- left atrial
- glycemic control
- patient reported